Figure 2.
Representative image of metastatic uLMS to the lungs (A) prior to and (B) after treatment with olaparib. Note the fluorodeoxyglucose-avid lesions in the bilateral lungs are dramatically reduced after olaparib treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.